1. A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia. (10th October 2013) Authors: Grinfeld, Jacob; Gerrard, Gareth; Alikian, Mary; Alonso‐Dominguez, Juan; Ale, Sakuntala; Valgañon, Mikel; Nteliopoulos, Georgios; White, Deborah; Marin, David; Hedgley, Corinne; O'Brien, Stephen; Clark, Richard; Goldman, John M.; Milojkovic, Dragana; Apperley, Jane F.; Foroni, Letizia Journal: British journal of haematology Issue: Volume 163:Number 5(2013:Dec.) Page Start: 631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase. Issue 1 (18th October 2014) Authors: Alonso‐Dominguez, Juan M.; Grinfeld, Jacob; Alikian, Mary; Marin, David; Reid, Alistair; Daghistani, Mustafa; Hedgley, Corinne; O'Brien, Stephen; Clark, Richard E.; Apperley, Jane; Foroni, Letizia; Gerrard, Gareth Journal: American journal of hematology Issue: Volume 90:Issue 1(2015:Jan.) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗